At-home ear vagus nerve stimulation plus computer brain training for thinking and mood
Official title: Combining At-Home Transcutaneous Auricular Vagus Nerve Stimulation and Computerized Cognitive Training for Neurocognitive Rehabilitation
Run by Medical University of South Carolina · NCT07517237 · Data updated 2026-11-12
This study will try at-home transcutaneous auricular vagus nerve stimulation combined with computerized cognitive training to see if it helps people aged 45-80 with self-reported cognitive changes improve thinking and mood.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 80 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | March 12, 2026 |
| Main results expected | October 26, 2026 |
| Study ends | October 26, 2026 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07517237 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45-80 with a self-reported change in cognition lasting at least six months that affects daily life, who have adequate sensorimotor and language ability, stable medications, reliable Wi‑Fi and a Bluetooth-enabled phone or tablet, and no prior diagnosis of MCI or dementia are ideal candidates.
✕Probably not a fit
People with a prior diagnosis of mild cognitive impairment or dementia, unstable medications, major sensory or motor impairments preventing device use, contraindications to taVNS, or who cannot travel to Charleston, SC for MRI and study visits are unlikely to benefit from or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a non-randomized, single-arm pilot of a 2-week at-home intervention pairing transcutaneous auricular vagus nerve stimulation (taVNS) with computerized cognitive training (CCT) in adults with subjective cognitive and psychosocial complaints. Participants self-administer the taVNS and complete CCT at home and undergo standardized cognitive and mood assessments before and after the treatment period. Brain MRI scans are obtained at baseline and after the intervention to explore treatment-related changes in brain function. The primary aims are to determine feasibility and acceptability and to collect preliminary data on cognitive, mood, psychosocial, and neural outcomes.
Why it matters
Potential benefit: If successful, this combined at-home approach could provide an accessible, noninvasive option to improve thinking, mood, and daily functioning without frequent clinic visits.
How similar studies have gone: Small studies of taVNS and of computerized cognitive training have shown mixed but sometimes promising effects separately, while the specific combination used here is novel and largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: i. Ages 45-80 (inclusive) ii. Adequate sensorimotor function (including motor function of dominant hand to complete CCT) and verbal expressive abilities to complete all assessments. iii. Access to reliable Wi-Fi and a Bluetooth-enabled mobile phone or tablet with internet connection capable of supporting study procedures. iv. Self-reported change in cognitive functioning (e.g., memory, attention, thinking abilities) compared to prior functioning, persisting ≥ 6 months and associated with concern and/or impact on daily functioning. v. Is on fixed pharmacotherapy (i.e. stable dose of medication/s) for ≥ 4 weeks before enrollment, and expected to remain stable throughout study participation. This includes, but is not limited to, cholinesterase inhibitors, NMDA receptor antagonists, and antidepressants. Exclusion Criteria: i. Prior diagnosis of Mild Cognitive Impairment or Dementia (NIA-AA) or Mild or Major Neurocognitive Disorder (DSM-5). ii. taVNS contraindications (e.g., history of seizures, history of trauma or damage to ear, reduced/impaired sensation in the ear). iii. MRI contraindications (e.g., ferromagnetic implants, claustrophobia). iv. Presence of a neurological, medical, or psychiatric condition that is acute, unstable, or severe, and that, in the judgment of the study investigators, would significantly interfere with safe participation, valid assessment of cognition or mood, or interpretation of study outcomes. v. Enrolled in a clinical trial or has received an investigational medication or device in the last 30 days that may impact cognition or mood. vi. For female participants, a positive pregnancy test if still menstruating within the past 12 months.
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Stephanie Aghamoosa, PhD — Medical University of South Carolina
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Immersive nature-based wellbeing program for older adults with cognitive impairment
A nature-inspired immersive virtual reality program is being tested to see if it can improve well-being and daily function for older adults with mild to moderate cognitive impairment.
-
Can a phone version of the Mini-Cog identify cognitive impairment before surgery?
This study tests whether a telephone-based Mini-Cog can reliably detect cognitive impairment in adults 65 and older before they have surgery.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
Structured Receptive Music to Help with Care During Bathing for People with Dementia
A structured daily music program used during hygiene care is being tested to see if it reduces refusals of care by residents with dementia in French nursing homes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.